Early phase drug discovery research requires the highest level of accurate and reproducible testing in order to give you the proof to move confidently forward. While Likarda developed and uses a proprietary approach to 3D cell-based testing, the results of these types of tests and others rely on the integrity of the data. In an environment where 'time is money' Likarda clients rely on the speed at which the company can provide quick and accurate results. By investing in robots like the INTEGRA VIAFLO ASSIST, Likarda has managed to bring speed, accuracy, precision and flexibility to its research and drug discovery.
Given the multi-well microplates used in Likarda contract research, having multi-channel pipettes is essential to workflow. After careful review of different automation solutions Likarda chose the INTEGRA VIAFLO ASSIST to run a single plate at a time for preliminary experiments, early assay development or pilot studies. They have found that the VIAFLO ASSIST removes the risk of less reproducible results compared to manual pipetting, and its electronic pipettes increase the reproducibility of prolonged pipetting protocols such as serial dilutions, plate filling, and reagent addition. Further Likarda reports that the intuitive touchscreen control software and ergonomic one-handed operation of the affordably-priced VIAFLO ASSIST has enabled them to save time developing high throughput assays and lower the cost of this contract work for its customers.
To watch the Likarda VIAFLO ASSIST video, please visit: https://www.integra-biosciences.com/en/news/3d-cell-culture-approach-using-multichannel-pipetting-robot.
For further information on the VIAFLO ASSIST, please visit: www.integra-biosciences.com or contact INTEGRA Biosciences in Europe / Asia on +41-81-286-9530 / firstname.lastname@example.org or in North / South America on +1-603-578-5800 / US@integra-biosciences.com.
INTEGRA Biosciences (https://www.integra-biosciences.com) is a leading provider of high-quality laboratory tools for liquid handling and media preparation. The company is committed to creating innovative solutions which fulfil the needs of its customers in research, diagnostics and quality control within the life science markets and medical industry. Today, INTEGRA innovative laboratory products are widely used all around the world. More than 90 distribution-partners form a worldwide sales network providing responsive and competent services to customers. These distribution partners are supported by a highly motivated and experienced team of specialists at the company headquarters in Zizers, Switzerland and Hudson, NH, USA. INTEGRA is an ISO 9001 certified company.
Likarda LLC (www.likarda.com) is a cutting-edge biotech research laboratory for science entrepreneurs, partners for bio consortiums, and contract research organizations (CRO). The company combine comprehensive early-phase discovery research with consultative and analytical services so that you can move ahead in the drug discovery process with confidence, efficiency, and success at an affordable rate. Likarda focus on bringing to market disruptive technologies that improve healthcare outcomes and lower costs for pets and people alike. Likarda uses a proprietary cell culture system to create 3D cell clusters, or miniaturized organs. This system has applications in markets ranging from drug discovery and development to cell-based transplantation and regenerative medicine.
Automating Early Stage Cell Based Assay Development
Early phase drug discovery research requires the highest level of accurate and reproducible testing in order to give you the proof to move confidently forward
| July 18, 2017
Categories: White Papers and Application Notes